Events

Previous Events

Contact person

Nicole Mastrell

Nicole Mastrell

Event Manager & PA to CEO

nm@mva.org

+45 6141 8634

MVA’s calendar provides you with an overview of life science events and courses taking place in Medicon Valley. To stay updated on life science events and courses relevant for you and your colleagues, sign up for the bi-weekly newsletter MVA Update which lists all upcoming events and courses or subscribe to our Event RSS Feed.

MVA Event
04 Sep 2012
08:00 to 10:00 /

IPR rules and issues in relation to the Korean market – is patenting different in Korea, compared to Europe and USA? Yes – there are differences in legislation and practices in addition to cultural differences, which together may lead to a different outcome in the patent application process in Korea compared to Europe or America. […]

Read more
MVA Event
15 Jun 2012
08:00 to 16:00 /

15 June 2012 / Lund / Sweden (8:00 – 16:00) Nordic Journal of Chemistry & Biotechnology/Kemivärlden Biotech med Kemisk Tidskrift, Medicon Valley Alliance, and MerckMillipore are, in collaboration, organizing an important networking event. The speakers will discuss current issues in drug formulation and QA. The seminar will be held in English and will feature about 15 exhibitors […]

Read more
MVA Event
04 Jun 2012
Meet the Ambassadors /

Are you looking to build strong life science relations in the US, Japan or South Korea? Now is your chance to take action! Our ambassadors are in Denmark and Sweden in June and are looking forward to meeting you. 4–8 June: Thomas Jonsson, Life Science Ambassador to Japan and South Korea is in Medicon Valley 11–15 […]

Read more
MVA Event
28 May 2012
08:00 to 10:00 /

At this networking meeting, patent experts from Høiberg A/S will talk about why it is still possible to patent personalized medicine and diagnostic methods following the recent decision (Mayo vs. Prometheus) from the US Supreme Court? You will be guide through the aftermath of the Prometheus decision. Additionally the meeting will focus on strategies to […]

Read more
MVA Event
22 May 2012
08:00 to 10:00 /

At this networking meeting, patent experts from Høiberg A/S will talk about why it is still possible to patent personalized medicine and diagnostic methods following the recent decision (Mayo vs. Prometheus) from the US Supreme Court? You will be guide through the aftermath of the Prometheus decision. Additionally the meeting will focus on strategies to […]

Read more
MVA Event
25 Apr 2012
16:30 to 18:00 /

Members of Medicon Valley Alliance are invited to attend the Ordinary General Meeting 2012. Agenda Election of chairperson. The Board of Directors’ report on MVA’s activities in the past year. Presentation of the annual report, including auditor’s report, adoption of the annual report and the establishment of the Board of Director’s remuneration. Resolution on the […]

Read more
MVA Event
17 Apr 2012
09:00 to 16:00 /

17 April 2012 / Ørestad / Denmark Medicon Valley Alliance in cooperation with DNB invites you to participate in a network meeting on how to attract investors and industry partners to a life science company. At the meeting you will also have the opportunity to present you technology / business plan to any of the […]

Read more
MVA Event
22 Mar 2012
15:00 to 18:00 /

Hear about MVA and our networks and initiatives. Get an insight into what value your organization gains from your membership of MVA.  Learn more about how MVA works to maintain and develop the attractiveness of Medicon Valley. 22 March 2012 / Ørestad / Denmark Join other members and non-members at the introductory meeting to MVA […]

Read more
MVA Event
28 Feb 2012
10:00 to 15:00 /

This seminar will address several of today’s key challenges in drug development leading up to clinical proof of concept. The agenda brings together a panel of speakers from academia, pharmaceutical companies and solution providers to discuss key issues from formulation design right through to effective clinical trial planning. The final session w ill discuss how […]

Read more
MVA Event
27 Feb 2012
08:30 to 13:00 /

Organotypic 3D-cell-culture systems are implemented at various stages in the compound development process for de-risking new drug candidates and can provide a wealth of meaningful efficacy and toxicology data. A growing list of publications confirms the striking similarities of these systems to in vivo tissue, clearly underlining their high potential value to the pharmaceutical industry. […]

Read more